The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The Cellular Target of Histatin 5 on Candida albicans Is the Energized Mitochondrion
Open accessAbstract
Histatin 5 is a human basic salivary peptide with strong fungicidal properties in vitro. To elucidate the mechanism of action, the effect of histatin 5 on the viability of Candida albicans cells was studied in relation to its membrane perturbing properties. It was found that both the killing activity and the membrane perturbing activity, studied by the influx of a DNA-specific marker propidium iodide, were inhibited by high salt conditions and by metabolic inhibitors, like sodium azide. In addition, exposure to histatin 5 resulted in a loss of the mitochondrial transmembrane potential in situ, measured by the release of the potential-dependent distributional probe rhodamine 123. Localization studies using tetramethylrhodamine isothiocyanate-labeled histatin 5 or fluorescein isothiocyanate-labeled histatin 5 showed a granular intracellular distribution of the peptide, which co-localized with mitotracker orange, a permeant mitochondria-specific probe. Like the biological effects, uptake of labeled histatin 5 was inhibited by mitochondrial inhibitors and high salt conditions. Our data indicate that histatin 5 is internalized, and targets to the energized mitochondrion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibodies: A laboratory manual
J.L. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90307-1 · Cited by 5,089
Manual of Methods for General Bacteriology
Jones, D. (1981) · Journal of Clinical Pathology · doi:10.1136/jcp.34.9.1069-c · Cited by 2,370
Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305
Cationic peptides: a new source of antibiotics
Hancock, R. E. W., & Lehrer, R. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01156-6 · Cited by 1,336
Hancock, R. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,096
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.
Lehrer, R. I., Barton, A., Daher, K. A., Harwig, S. S., Ganz, T., & Selsted, M. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114198 · Cited by 715
Oppenheim, F. G., Xu, T., McMillian, F. M., Levitz, S. M., Diamond, R. D., Offner, G. D., & Troxler, R. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68522-9 · Cited by 652
Archaeal-eubacterial mergers in the origin of Eukarya: phylogenetic classification of life.
Margulis, L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1071 · Cited by 354
Defensins: Endogenous antibiotic peptides of animal cells
Lehrer, R. I., Ganz, T., & Selsted, M. E. (1991) · Cell · doi:10.1016/0092-8674(91)90632-9 · Cited by 348
Matsuzaki, K., Murase, O., Fujii, N., & Miyajima, K. (1995) · Biochemistry · doi:10.1021/bi00019a033 · Cited by 308
Cited by
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Diversity of antimicrobial peptides and their mechanisms of action
Epand, R. M., & Vogel, H. J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00198-4 · Cited by 1,358
Mammalian defensins in the antimicrobial immune response
Selsted, M. E., & Ouellette, A. J. (2005) · Nature Immunology · doi:10.1038/ni1206 · Cited by 1,203
Cationic peptides: effectors in innate immunity and novel antimicrobials
Hancock, R. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00092-5 · Cited by 978
Saliva – the defender of the oral cavity
Amerongen, A. N., & Veerman, E. (2002) · Oral Diseases · doi:10.1034/j.1601-0825.2002.1o816.x · Cited by 760
Self-citationRole of lipids in the interaction of antimicrobial peptides with membranes
Teixeira, V., Feio, M. J., & Bastos, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.005 · Cited by 692
Human Antimicrobial Peptides: Defensins, Cathelicidins and Histatins
De Smet, K., & Contreras, R. (2005) · Biotechnology Letters · doi:10.1007/s10529-005-0936-5 · Cited by 560
Human Antimicrobial Peptides and Proteins
Wang, G. (2014) · Pharmaceuticals · doi:10.3390/ph7050545 · Cited by 528
The Secretion, Components, and Properties of Saliva
Carpenter, G. H. (2013) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030212-182700 · Cited by 507
Ouhara, K., Komatsuzawa, H., Yamada, S., Shiba, H., Fujiwara, T., Ohara, M., Sayama, K., Hashimoto, K., Kurihara, H., & Sugai, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki103 · Cited by 428
Antimicrobial Peptides: Properties and Applicability
Hof, W. V. T., Veerman, E. C. I., Helmerhorst, E. J., & Amerongen, A. V. N. (2001) · Biological Chemistry · doi:10.1515/bc.2001.072 · Cited by 354
Self-citationProperties and mechanisms of action of naturally occurring antifungal peptides
van der Weerden, N. L., Bleackley, M. R., & Anderson, M. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1260-1 · Cited by 271
Antifungal Peptides as Therapeutic Agents
Fernández de Ullivarri, M., Arbulu, S., Garcia-Gutierrez, E., & Cotter, P. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00105 · Cited by 264
Nibbering, P. H., Ravensbergen, E., Welling, M. M., van Berkel, L. A., van Berkel, P. H. C., Pauwels, E. K. J., & Nuijens, J. H. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1469-1476.2001 · Cited by 261
CCL28 Has Dual Roles in Mucosal Immunity as a Chemokine with Broad-Spectrum Antimicrobial Activity
Hieshima, K., Ohtani, H., Shibano, M., Izawa, D., Nakayama, T., Kawasaki, Y., Shiba, F., Shiota, M., Katou, F., Saito, T., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1452 · Cited by 260
Antimicrobial peptides – Advances in development of therapeutic applications
Luong, H. X., Thanh, T. T., & Tran, T. H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118407 · Cited by 258
Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin
van der Kraan, M. I. A., Groenink, J., Nazmi, K., Veerman, E. C. I., Bolscher, J. G. M., & Nieuw Amerongen, A. V. (2004) · Peptides · doi:10.1016/j.peptides.2003.12.006 · Cited by 254
Self-citationMesa-Arango, A. C., Trevijano-Contador, N., Román, E., Sánchez-Fresneda, R., Casas, C., Herrero, E., Argüelles, J. C., Pla, J., Cuenca-Estrella, M., & Zaragoza, O. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03570-14 · Cited by 232
Histatins: Antimicrobial peptides with therapeutic potential
Kavanagh, K., & Dowd, S. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022971 · Cited by 223
Antimicrobial peptides: promising compounds against pathogenic microorganisms
Cruz, J., Ortiz, C., Guzmán, F., Fernández-Lafuente, R., & Torres, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140217110155 · Cited by 166
Andrés, M. T., Viejo-Díaz, M., & Fierro, J. F. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01597-07 · Cited by 114
Discovery and development of a synthetic peptide derived from lactoferrin for clinical use
Brouwer, C. P. J. M., Rahman, M., & Welling, M. M. (2011) · Peptides · doi:10.1016/j.peptides.2011.07.017 · Cited by 90
Herrero de Dios, C., Roman, E., Alonso Monge, R., & Pla, J. (2010) · Current Protein & Peptide Science · doi:10.2174/138920310794557655 · Cited by 55
Yount, N. Y., Andrés, M. T., Fierro, J. F., & Yeaman, M. R. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.07.024 · Cited by 51
Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response
Mercer, D. K., & O'Neil, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02177 · Cited by 50
Baev, D., Rivetta, A., Li, X. S., Vylkova, S., Bashi, E., Slayman, C. L., & Edgerton, M. (2003) · Infection and Immunity · doi:10.1128/iai.71.6.3251-3260.2003 · Cited by 36
Novel mitochondrial complex I-inhibiting peptides restrain NADH dehydrogenase activity
Xue, Y.-P., Kao, M.-C., & Lan, C.-Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-50114-2 · Cited by 25
Metadata
- Authors
- Helmerhorst, E. J., Breeuwer, P., van 't Hof, W., Walgreen-Weterings, E., Oomen, L. C. J. M., Veerman, E. C. I., Amerongen, A. V. N., & Abee, T.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-03
- Volume
- 274
- Issue
- 11
- Pages
- 7286-7291
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2091874747
- Cited by
- 283
- References
- 26
- FWCI
- 10.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.